COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?
作者信息
Movahedi Nasim, Ziaee Vahid
机构信息
Children's Medical Center, Pediatrics Center of Excellence, Tehran, Iran.
Department of Pediatrics, Tehran University of Medical Science, Tehran, Iran.
出版信息
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):86. doi: 10.1186/s12969-021-00570-w.
Abstract
摘要
相似文献
1
COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?新型冠状病毒肺炎与肌炎；是真正的皮肌炎还是病毒感染后持续性肌炎？
Pediatr Rheumatol Online J. 2021 Jun 10;19(1):86. doi: 10.1186/s12969-021-00570-w.
2
COVID-19-associated myositis may be dermatomyositis.新型冠状病毒肺炎相关肌炎可能是皮肌炎。
Muscle Nerve. 2021 Jan;63(1):E9-E10. doi: 10.1002/mus.27105. Epub 2020 Nov 15.
3
Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis.一位幼年皮肌炎患者的抗 Tif1γ和 Mi-2 肌炎特异性自身抗体。
Acta Derm Venereol. 2020 Aug 18;100(15):adv00238. doi: 10.2340/00015555-3594.
4
Diagnosis and treatment of polymyositis and dermatomyositis.多发性肌炎和皮肌炎的诊断与治疗
Compr Ther. 1990 Apr;16(4):16-24.
5
Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits.补体在自身免疫性炎性肌病中的作用、肌炎相关抗体、COVID-19 关联和肌肉淀粉样沉积。
Expert Rev Clin Immunol. 2022 Apr;18(4):413-423. doi: 10.1080/1744666X.2022.2054803. Epub 2022 Mar 27.
6
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.重新定义皮肌炎：一种新诊断标准的描述，该标准可区分单纯皮肌炎与具有皮肌炎特征的重叠性肌炎。
Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222.
7
[Dermatomyositis and polymyositis].[皮肌炎和多发性肌炎]
Med Welt. 1972 Jan 15;23(3):77-8.
8
[Polymyositis--dermatomyositis: advances in diagnosis and therapy].[多发性肌炎——皮肌炎：诊断与治疗进展]
Przegl Lek. 1987;44(3):345-50.
9
[Antinuclear and anticytoplasmic antibodies in polymyositis and dermatomyositis].[多发性肌炎和皮肌炎中的抗核抗体和抗细胞质抗体]
Nihon Naika Gakkai Zasshi. 1986 Nov;75(11):1597-601. doi: 10.2169/naika.75.1597.
10
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.伴或不伴肌炎相关自身抗体的临床无肌病性皮肌炎患者循环抗 MDA5 自身抗体的临床特征差异。
Respir Med. 2018 Jul;140:1-5. doi: 10.1016/j.rmed.2018.05.010. Epub 2018 May 22.
引用本文的文献
1
Severe Post-Viral Polymyositis after COVID-19 in Childhood: A Case Report and Literature Review.儿童新冠病毒感染后严重病毒性多肌炎：一例报告及文献综述
Children (Basel). 2024 Aug 20;11(8):1011. doi: 10.3390/children11081011.
2
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
3
The impact of the COVID-19 pandemic on patients with juvenile idiopathic inflammatory myopathies.COVID-19 大流行对青少年特发性炎性肌病患者的影响。
Pediatr Rheumatol Online J. 2023 Sep 12;21(1):100. doi: 10.1186/s12969-023-00873-0.
4
Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies.新型冠状病毒对青少年特发性炎性肌病临床表现的影响。
Pediatr Rheumatol Online J. 2023 Aug 11;21(1):82. doi: 10.1186/s12969-023-00861-4.
5
Infection, Dysbiosis and Inflammation Interplay in the COVID Era in Children.在新冠时代，感染、微生态失调和炎症相互作用于儿童。
Int J Mol Sci. 2023 Jun 29;24(13):10874. doi: 10.3390/ijms241310874.
6
Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.新型冠状病毒感染后(post-acute)的后遗症：肌肉骨骼疾病与疼痛。
Phys Med Rehabil Clin N Am. 2023 Aug;34(3):585-605. doi: 10.1016/j.pmr.2023.04.008. Epub 2023 Apr 14.
7
COVID-19 musculoskeletal involvement in children.儿童新冠病毒感染相关的肌肉骨骼表现
Front Pediatr. 2023 May 19;11:1200877. doi: 10.3389/fped.2023.1200877. eCollection 2023.
8
Case report: Unusual patient with dermatomyositis associated with SARS-CoV-2 infection.病例报告：一名患有与SARS-CoV-2感染相关的皮肌炎的特殊患者。
Front Neurol. 2023 May 19;14:1122475. doi: 10.3389/fneur.2023.1122475. eCollection 2023.
9
Post-COVID-19 Polymyositis: A Case Report.新型冠状病毒肺炎后多发性肌炎：一例报告
Cureus. 2022 Nov 1;14(11):e30991. doi: 10.7759/cureus.30991. eCollection 2022 Nov.
10
A case series of dermatomyositis following SARS-CoV-2 vaccination.2019冠状病毒病疫苗接种后皮肌炎病例系列
Front Med (Lausanne). 2022 Nov 7;9:1013378. doi: 10.3389/fmed.2022.1013378. eCollection 2022.
本文引用的文献
1
Covid-19-Associated Myopathy Caused by Type I Interferonopathy.由I型干扰素病引起的新型冠状病毒肺炎相关性肌病
N Engl J Med. 2020 Dec 10;383(24):2389-2390. doi: 10.1056/NEJMc2031085. Epub 2020 Nov 20.
2
Dermatomyositis during COVID-19 Pandemic (A Case Series): Is there a Cause Effect Relationship?新冠疫情期间的皮肌炎（病例系列）：是否存在因果关系？
J Assoc Physicians India. 2020 Nov;68(11):20-24.
3
COVID-19-associated myositis may be dermatomyositis.新型冠状病毒肺炎相关肌炎可能是皮肌炎。
Muscle Nerve. 2021 Jan;63(1):E9-E10. doi: 10.1002/mus.27105. Epub 2020 Nov 15.
4
Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran.伊朗首次报告 45 例与 SARS-CoV-2 感染相关的多系统炎症综合征。
Epidemiol Infect. 2020 Aug 28;148:e196. doi: 10.1017/S095026882000196X.
5
Myositis as a manifestation of SARS-CoV-2.肌炎作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的一种表现形式。
Ann Rheum Dis. 2021 Mar;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. Epub 2020 Apr 23.
6
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.一系列接受免疫抑制靶向治疗的慢性关节炎患者的 COVID-19 临床病程。
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
7
Influenza-associated myositis in children.儿童流感相关性肌炎
Infection. 2004 Aug;32(4):199-203. doi: 10.1007/s15010-004-4003-2.
Zotero 插件